Trials / Withdrawn
WithdrawnNCT03193359
Open Label Study of BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Patients With Chronic Migraine
A Multicenter, Open-label, Safety, Tolerability and Efficacy Study of BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Patients With Chronic Migraine
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study is an open-label extension study to evaluate the safety, tolerability and efficacy of BOTOX® as headache prophylaxis in Chinese patients with chronic migraine who have successfully completed the double-blind study: 1313-301-008.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | botulinum toxin Type A | Botulinum toxin Type A (BOTOX®) IM 155U to 195U injections in head/neck areas. |
Timeline
- Start date
- 2018-01-15
- Primary completion
- 2021-09-09
- Completion
- 2021-09-09
- First posted
- 2017-06-20
- Last updated
- 2017-07-14
Source: ClinicalTrials.gov record NCT03193359. Inclusion in this directory is not an endorsement.